« Did Drugmakers Violate India’s Patent Laws? | Main | Actelion Strikes Back! »

04/07/2011

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b014e6074ec17970c

Listed below are links to weblogs that reference Mylan Sues FDA in Race for Lipitor:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

The whole back story and description of the uncertainty for the future as reported by Fortune
http://money.cnn.com/2011/05/03/news/companies/lipitor_ranbaxy_full_version.fortune/index.htm#lipitor

Vishal

Recall last month, Mylan had sued FDA in the US district court seeking a forfeiture of Ranbaxy’s 180 days exclusivity on Lipitor. A hearing on the motions is scheduled for 28th April at 9:30 am (US Time).


The decision could go either way, and I expect a 10% stock price movement either way depending on the outcome. In such a case I would recommend a straddle on Ranbaxy as significant volatility in stock price is expected.

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada